Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ReConnect is a proprietary essential oil blend developed by Young Living, specifically formulated to support mental focus, emotional grounding, and a positive outlook. The formulation is a complex mixture of several essential oils, including Sacred Frankincense (*Boswellia sacra*), Melissa (*Melissa officinalis*), Lavender (*Lavandula angustifolia*), Myrrh (*Commiphora myrrha*), Sandalwood (*Santalum album*), and others. It has been evaluated in clinical research, specifically a Phase 2 trial (NCT02382263), for its potential to improve quality of life, relaxation, and sleep patterns in children aged 3 to 9 with Autism Spectrum Disorder (ASD). The blend is intended for aromatic or topical use.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ReConnect.